Philips showcases latest patient-driven sleep and respiratory solutions at the ERSIC 2015

September 28, 2015, Amsterdam, Netherlands – Philips Respironics, a business of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.

Sleep: Patient-driven designs for successful OSA treatment

Philips’ sleep therapy portfolio connects the provider and the patient at the most important points in the health continuum, from diagnosis to compliance and ongoing use and resupply. The following new sleep-disordered breathing solutions will be on display during ERS 2015:

Dream Family: The new, full integrated, patient-centric sleep therapy solution from Philips featuring a connected positive airway pressure (PAP) therapy device, complementary mask line, and engagement tools to improve care for obstructive sleep apnea (OSA) patients. The Dream Family integrated solution includes the DreamStation PAP device, DreamWear mask, and DreamMapper1 personalized coaching tool. The Dream Family, which will become available to patients and care teams in select countries after October 2015, is designed to engage patients in natural, comfortable and effective sleep therapy while seamlessly connecting them to their care teams for optimal therapy management.

Amara View: A minimal contact, full-face mask, the under-the-nose design of Amara View prevents red marks, discomfort and irritation on the bridge of the nose. It also offers the widest field of vision of leading full face masks2.

“As a leader in sleep apnea treatment innovation, Philips continuously aims to expand its CPAP mask offerings with an emphasis on patient comfort,” said Mark D’Angelo, Sleep Business Leader of Philips. “By addressing patient concerns, like limited mobility and mask-related irritation, we can provide patients with more personalized options to help them adapt to and stick with their OSA treatment, and get the sleep they deserve.”

Respiratory: Comprehensive COPD disease state management solutions
Philips Respironics is committed to providing one unified approach to COPD care – coordinated, consistent, uninterrupted and centered around the patient and the home. Our goal is to help reduce hospitalizations, improve patient care, maximize clinician resources and support patients in living more active, fulfilling lives.

More HCB News